1. Home
  2. UL vs BSX Comparison

UL vs BSX Comparison

Compare UL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unilever PLC

UL

Unilever PLC

HOLD

Current Price

$64.36

Market Cap

153.0B

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$88.32

Market Cap

137.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UL
BSX
Founded
1930
1979
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.0B
137.8B
IPO Year
N/A
1992

Fundamental Metrics

Financial Performance
Metric
UL
BSX
Price
$64.36
$88.32
Analyst Decision
Strong Buy
Analyst Count
0
17
Target Price
N/A
$125.88
AVG Volume (30 Days)
2.1M
9.0M
Earning Date
07-31-2025
02-04-2026
Dividend Yield
3.53%
N/A
EPS Growth
N/A
54.68
EPS
3.32
1.87
Revenue
$70,194,950,090.00
$19,349,000,000.00
Revenue This Year
N/A
$21.05
Revenue Next Year
N/A
$11.44
P/E Ratio
$19.33
$48.15
Revenue Growth
N/A
21.61
52 Week Low
$61.11
$85.98
52 Week High
$73.87
$109.50

Technical Indicators

Market Signals
Indicator
UL
BSX
Relative Strength Index (RSI) 52.09 27.89
Support Level $61.78 $87.22
Resistance Level $65.36 $100.90
Average True Range (ATR) 0.64 1.91
MACD -0.18 -0.71
Stochastic Oscillator 61.31 8.69

Price Performance

Historical Comparison
UL
BSX

About UL Unilever PLC

Unilever is a diversified beauty, wellbeing, and personal care (44% of 2024 sales by value), homecare (20%), and packaged food (36%) company. Its brands include Dove personal-care products, Knorr soups and sauces, Hellmann's mayonnaise, Axe and Rexona deodorants, and TRESemmé haircare. The firm has been acquisitive in recent years; notable purchases include Paula's Choice, Liquid I.V., Horlicks, and Wild deodorants. The company derives 58% of its sales from emerging markets and 42% from developed markets. The US is its largest market, accounting for around 20% of sales, followed by India, which accounts for 11% of sales.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: